Eidos Therapeutics

Venture-backed company · Stage unknown
Rounds on record
1
Latest round
Mar 29, 2018
Form D equity offering
Latest round size
$26.0M
As of · the latest observation of this company; each round carries its own date

What matters now

  1. 1 investor
    named

    1 investor on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
Drawing the relationship network…

Facts

Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1

Financing history

1 round
  1. Mar 29, 2018
    Form D equity offering · $26.0M (form d sold)
    Fact Form D · “Eidos Therapeutics, Inc. Form D, first filed 2018-04-12”

Investors on record

2 edges

Ownership and outcomes

none on record
Outcome stated by investors

Listed on 1 firm portfolio page; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.

Evidence: 1 listingeach firm's own card, as read
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.

Credit relationships

none on record
No lender position matched to this company.

People

0 officers, 0 directors
No officer or director on record.

Timeline

0 events
No dated event on record.

Evidence

3 observations
Every observation on this company
  • Listed on portfolio page: RA Capital Management, LP Oct 1, 2026 Fact Firm website
  • Listed on portfolio page: RA Capital Management, LP Sep 16, 2026 Fact Firm website
  • Listed on portfolio page: RA Capital Management, LP Sep 15, 2026 Fact Firm website